Insider Selling: U.S. Physical Therapy, Inc. (NYSE:USPH) Insider Sells 2,500 Shares of Stock

U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) insider Eric Joseph Williams sold 2,500 shares of the business's stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $104.22, for a total value of $260,550.00. Following the transaction, the insider now directly owns 16,814 shares of the company's stock, valued at $1,752,355.08. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Eric Joseph Williams also recently made the following trade(s):

• On Monday, March 4th, Eric Joseph Williams sold 1,500 shares of U.S. Physical Therapy stock. The shares were sold at an average price of $104.96, for a total value of $157,440.00.

U.S. Physical Therapy Trading Up 1.4 %

USPH traded up $1.44 on Tuesday, reaching $106.41. 56,779 shares of the company's stock were exchanged, compared to its average volume of 68,903. The company's 50 day moving average is $105.39 and its 200-day moving average is $97.00. The company has a market cap of $1.60 billion, a price-to-earnings ratio of 86.51, a PEG ratio of 4.05 and a beta of 1.39. U.S. Physical Therapy, Inc. has a twelve month low of $78.08 and a twelve month high of $124.11. The company has a debt-to-equity ratio of 0.28, a quick ratio of 2.16 and a current ratio of 2.16.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Tuesday, May 7th. The company reported $0.51 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.58 by ($0.07). The business had revenue of $155.70 million for the quarter, compared to analyst estimates of $153.30 million. U.S. Physical Therapy had a return on equity of 8.03% and a net margin of 4.72%. The firm's revenue for the quarter was up 4.8% compared to the same quarter last year. During the same period last year, the company posted $0.59 EPS. Equities analysts predict that U.S. Physical Therapy, Inc. will post 2.9 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 14th. Stockholders of record on Thursday, May 23rd will be paid a dividend of $0.44 per share. This represents a $1.76 annualized dividend and a dividend yield of 1.65%. The ex-dividend date is Wednesday, May 22nd. U.S. Physical Therapy's dividend payout ratio (DPR) is currently 143.09%.

Hedge Funds Weigh In On U.S. Physical Therapy

Institutional investors and hedge funds have recently made changes to their positions in the business. RK Capital Management LLC bought a new stake in U.S. Physical Therapy in the fourth quarter valued at $6,166,000. Norden Group LLC grew its position in U.S. Physical Therapy by 1,841.6% in the first quarter. Norden Group LLC now owns 63,938 shares of the company's stock worth $7,217,000 after buying an additional 60,645 shares during the last quarter. Envestnet Asset Management Inc. grew its position in U.S. Physical Therapy by 53.2% in the third quarter. Envestnet Asset Management Inc. now owns 163,956 shares of the company's stock worth $15,040,000 after buying an additional 56,957 shares during the last quarter. Bahl & Gaynor Inc. grew its position in U.S. Physical Therapy by 95.5% in the fourth quarter. Bahl & Gaynor Inc. now owns 100,315 shares of the company's stock worth $9,343,000 after buying an additional 49,013 shares during the last quarter. Finally, Schroder Investment Management Group grew its holdings in shares of U.S. Physical Therapy by 11.0% during the fourth quarter. Schroder Investment Management Group now owns 427,217 shares of the company's stock valued at $39,791,000 after buying an additional 42,281 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on USPH. StockNews.com upgraded U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Monday, March 18th. Barrington Research restated an "outperform" rating and set a $122.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, May 9th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of U.S. Physical Therapy from $99.00 to $117.00 and gave the stock an "overweight" rating in a research report on Wednesday, March 13th. One investment analyst has rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, U.S. Physical Therapy has a consensus rating of "Moderate Buy" and an average target price of $125.67.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.